By Dr Justine Odionyi, Head of Disease, HIV, DNDi

Including children in trials, shaping regulation locally, could deliver safer, more effective therapies in Africa.

When three-year-old Faith heard her name called by the nurse in the visceral leishmaniosis ward in Kacheliba Sub-County Referral Hospital in West Pokot, Kenya, she burst into tears. Her cry echoed through the ward as her 25th and 26th painful injections were administered. She had already spent 13 days in the hospital and still had four more days and eight more injections to endure.

Read the viewpoint published in Nature Africa in English and French